Adtalem Global Education (NYSE:CVSA) CEO Sells $359,446.68 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 2,762 shares of the company’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $130.14, for a total value of $359,446.68. Following the transaction, the chief executive officer owned 426,562 shares of the company’s stock, valued at approximately $55,512,778.68. This trade represents a 0.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Down 0.1%

Shares of CVSA stock opened at $128.23 on Monday. Adtalem Global Education Inc. has a 12 month low of $86.97 and a 12 month high of $156.26. The firm has a market capitalization of $4.36 billion, a price-to-earnings ratio of 19.97, a PEG ratio of 1.07 and a beta of 0.62. The stock’s 50 day simple moving average is $120.70. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.36.

Adtalem Global Education (NYSE:CVSA) last issued its quarterly earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The company had revenue of $487.03 million during the quarter. During the same quarter last year, the firm earned $1.92 earnings per share. The firm’s quarterly revenue was up 4.5% compared to the same quarter last year. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, equities analysts predict that Adtalem Global Education Inc. will post 8.04 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on CVSA. Zacks Research lowered Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 25th. Truist Financial upped their price target on Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a report on Friday, May 22nd. Wall Street Zen upgraded Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Barrington Research reiterated an “outperform” rating and set a $170.00 price target on shares of Adtalem Global Education in a report on Monday, June 8th. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, Adtalem Global Education currently has an average rating of “Moderate Buy” and an average target price of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.